CIK 0001850270 · <br>Emerging growth company
PROKIDNEY CORP.
Sign in to watch- Ticker
- PROK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- EIN
- 981586514
- Phone
- 336-999-7028
- Business address
- 2000 FRONTIS PLAZA BLVD., SUITE 250, WINSTON-SALEM, NC, 27103
- Former names
- Social Capital Suvretta Holdings Corp. III
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,067,773
- in 1 filing
Net −$1,067,773. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-01 | Coulston James Chief Financial Officer | Grant or award · Employee stock option (right to buy) | +650,000 | 650,000 | ||
| 2025-02-04 | Legorreta Pablo G. Director | Conversion | +532,535 | 23,150,444 | ||
| 2025-02-04 | Legorreta Pablo G. Director | Other disposition | −532,535 | 22,617,909 | ||
| 2025-02-04 | Legorreta Pablo G. Director | Conversion · Class B Ordinary Shares | −532,535 | 88,107,426 | ||
| 2025-02-04 | Legorreta Pablo G. Director | Conversion · Common Units in ProKidney LP | −532,535 | 88,107,426 | ||
| 2025-02-04 | Pereira Brian JG Director | Conversion | +81,928 | 81,928 | ||
| 2025-02-04 | Pereira Brian JG Director | Conversion | +675,234 | 675,234 | ||
| 2025-02-04 | Pereira Brian JG Director | Conversion · Class B Ordinary Shares | −81,928 | 81,929 | ||
| 2025-02-04 | Pereira Brian JG Director | Conversion · Common Units in ProKidney LP | −81,928 | 81,929 | ||
| 2025-02-04 | Pereira Brian JG Director | Conversion · Class B Ordinary Shares | −675,234 | 675,235 | ||
| 2025-02-04 | Pereira Brian JG Director | Conversion · Common Units in ProKidney LP | −675,234 | 675,235 | ||
| 2024-09-19 | Weber Darin J. Chief Regulatory Officer | Sale 10b5-1 | −16,412 | $2.50 | $41K | 103,480 |
| 2024-09-13 | Culleton Bruce Chief Executive Officer | Grant or award · Employee stock option (right to buy) | +500,000 | 500,000 | ||
| 2024-09-03 | Fox Jennifer A. Director | Grant or award · Director stock option (right to buy) | +9,535 | 9,535 | ||
| 2024-07-31 | Girolamo Todd C Chief Legal Officer | Conversion | +81,928 | 163,856 | ||
| 2024-07-31 | Girolamo Todd C Chief Legal Officer | Conversion · Class B Ordinary Shares | −81,928 | 163,857 | ||
| 2024-07-31 | Girolamo Todd C Chief Legal Officer | Conversion · Common Units in ProKidney LP | −81,928 | 163,857 | ||
| 2024-07-26 | Weber Darin J. Chief Regulatory Officer | Sale 10b5-1 | −826 | $2.50 | $2K | 119,892 |
| 2024-06-18 | Weber Darin J. Chief Regulatory Officer | Sale 10b5-1 | −17,238 | $2.82 | $49K | 120,718 |
| 2024-06-13 | Legorreta Pablo G. Director | Purchase | +22,617,909 | $2.42 | $54.7M | 22,617,909 |
Page 4 of 12 · 231 trades